← Back to Search

Fitbit for Head and Neck Cancers

N/A
Waitlist Available
Led By Ryan J Li
Research Sponsored by OHSU Knight Cancer Institute
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up at study completion, an average of 10 days
Awards & highlights

Study Summary

This trial is studying the impact of virtual reality and Fitbit devices on postoperative recovery after head and neck surgery.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~at study completion, an average of 10 days
This trial's timeline: 3 weeks for screening, Varies for treatment, and at study completion, an average of 10 days for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Mean daily opioid use
Other outcome measures
Anxiety
Depression
Disposition on discharge
+5 more

Trial Design

4Treatment groups
Experimental Treatment
Active Control
Group I: Group 3 (Fitbit)Experimental Treatment2 Interventions
Beginning postoperative day 1, patients wear Fitbit daily with a goal of 2,000 steps until the day of discharge or until 14 days after surgery. Sleep data may also be evaluated from Fitbit devices.
Group II: Group 2 (VR)Experimental Treatment2 Interventions
Beginning postoperative day 1, patients use VR over 30 minutes up to 4 times daily on weekdays and 2 times daily on weekends until the day of discharge or until 14 days after surgery. Pre and post-VR pain scores will be obtained for each VR use.
Group III: Group 1 (VR, Fitbit)Experimental Treatment3 Interventions
Beginning postoperative day 1, patients use VR over 30 minutes up to 4 times daily on weekdays and 2 times daily on weekends, and wear Fitbit daily with a goal of 2,000 steps until the day of discharge, or until 14 days after surgery. Pre and post-VR pain scores will be obtained for each VR use. Sleep data may also be evaluated from Fitbit devices.
Group IV: Group 4 (questionnaire)Active Control1 Intervention
Patients do not use VR or wear Fitbit.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Fitbit
2021
N/A
~3560
Virtual Reality Device
2019
N/A
~230

Find a Location

Who is running the clinical trial?

OHSU Knight Cancer InstituteLead Sponsor
228 Previous Clinical Trials
2,090,595 Total Patients Enrolled
Oregon Health and Science UniversityOTHER
971 Previous Clinical Trials
6,845,898 Total Patients Enrolled
Ryan J LiPrincipal InvestigatorOHSU Knight Cancer Institute
3 Previous Clinical Trials
122 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
A Digital Intervention Protocol to Enhance Recovery After Head and Neck Surgery
Ryan Li, MD 2021. "A Digital Intervention Protocol to Enhance Recovery After Head and Neck Surgery". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04814524.
~21 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top